Answer to Question #7143 Submitted to "Ask the Experts"Category: Nuclear Medicine Patient Issues — Therapeutic Nuclear Medicine The following question was answered by an expert in the appropriate field: Q
The mathematical model in the National Council on Radiation Protection and Measurements (NCRP) Report 155 (Appendix B) for thyroid cancer patients is different than the model used in the Nuclear Regulatory Commission Regulatory Guide 8.39. One has two compartments, the other three; and the effective half-lives are not the same (5.8 days vs 7.3 days respectively). Since the NCRP 155 publication is the more recent of the two, is that the "preferred" model to use?
A
The guidance provided in Reg. Guide 8.39 was reiterated more or less unchanged in NUREG-1556, Vol. 9, which was issued in 2005. The method described in these guides is a simple, generic method, intended to provide reasonable assurance that, when applied to any release situation, it will ensure that the primary requirement for patient release will be met. This primary requirement, stated in 10 CFR 35.75, is that the release is not likely to result in a dose to any individual in excess of 5 mSv.
Answer posted on January 22, 2008. The information and material posted on this Web site is intended as general reference information only. Specific facts and circumstances may alter the concepts and applications of materials and information described herein. The information provided is not a substitute for professional advice and should not be relied upon in the absence of such professional advice specific to whatever facts and circumstances are presented in any given situation. Answers are correct at the time they are posted on the Web site. Be advised that over time, some requirements could change, new data could be made available, or Internet links could change. For answers that have been posted for several months or longer, please check the current status of the posted information prior to using the responses for specific applications.
|
||||||||||||||||||